Evidence map›Paper›PMID 33308308›Full record

ArticleClinical epigenetics2020

Reproductive technologies, female infertility, and the risk of imprinting-related disorders.

Patricia Fauque, Jacques De Mouzon, Aviva Devaux, Sylvie Epelboin, Marie-José Gervoise-Boyer, Rachel Levy, Morgane Valentin, Géraldine Viot, Arianne Bergère, Claire De Vienne and 2 more

Open access · goldAbstract read
In one paragraph

Article in Clinical epigenetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Patricia FauqueCHU Dijon Bourgogne, Laboratoire de Biologie de la Reproduction - CECOS - Université Bourgogne Franche-Comté - INSERM UMR1231, Dijon, France. patricia.fauque@chu-dijon.fr.ORCID 0000-0002-9708-1710
Jacques De MouzonUnilabs, direction médicale, Clichy-La-Garenne, France.
Aviva DevauxCentre d'assistance medicale à la procreation, biologie de la reproduction, CHU Amiens, Amiens, France.
Sylvie EpelboinCentre d'assistance medicale à la procreation, gynécologie obstétrique, médecine de la reproduction, Université Paris 7 Diderot, groupe hospitalier Bichat Claude-Bernard, AP-HP, Paris, France.
Marie-José Gervoise-BoyerService de medecine et biologie de la reproduction, Hôpital Saint-Joseph, Marseille 8, France.
Rachel LevySorbonne Université, Saint Antoine Research Center, INSERM équipe Lipodystrophies genetiques et acquises, Service de biologie de la reproduction-CECOS, Hôpital Tenon, AP-HP, 75012, Paris, France.
Morgane ValentinDiagnostic antenatal, gynécologie obstétrique, Université Paris 7 Diderot, groupe hospitalier Bichat Claude-Bernard, AP-HP, Paris, France.
Géraldine ViotUnité de Génétique Clinique de La Muette, 50 rue Nicolo, 75116, Paris, France.
Arianne BergèreAgence de la Biomédecine, 1 avenue du stade de France, 93212, La Plaine Saint Denis, France.
Claire De VienneAgence de la Biomédecine, 1 avenue du stade de France, 93212, La Plaine Saint Denis, France.
Philippe JonveauxAgence de la Biomédecine, 1 avenue du stade de France, 93212, La Plaine Saint Denis, France.
Fabienne PessioneAgence de la Biomédecine, 1 avenue du stade de France, 93212, La Plaine Saint Denis, France.
Agence de la Biomédecine · FRInserm · FRUniversité Claude Bernard Lyon 1 · FRCentre Hospitalier Universitaire Amiens-Picardie · FRChimie Moléculaire, Macromoléculaire, Matériaux · FRHôpital Saint Joseph · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEpidemiological studies suggest that singletons born from assisted reproductive technologies (ART) have a high risk of adverse perinatal outcomes, specifically for imprinting disorders. Because ART processes take place at times when epigenetic reprogramming/imprinting are occurring, there is concern that ART can affect genomic imprints. However, little is currently known about the risk of imprinting defects according to the type of ART or the type of underlying female infertility. From the French national health database, a cohort of 3,501,495 singletons born over a 5-year period (2013-2017) following fresh embryo or frozen embryo transfers (fresh-ET or FET from in vitro fertilization), intrauterine insemination, or natural conception was followed up to early childhood. Based on clinical features, several syndromes/diseases involving imprinted genes were monitored. The effects of ART conception and the underlying cause of female infertility were assessed.

resultsCompared with infants conceived naturally, children born after fresh-ET had a higher prevalence of imprinting-related diseases, with an aOR of 1.43 [95% CI 1.13-1.81, p = 0.003]. Namely, we observed an increased risk of neonatal diabetes mellitus (1.96 aOR [95% CI 1.43-2.70], p < 0.001). There was an overall independent increase in risk of imprinting diseases for children with mothers diagnosed with endometriosis (1.38 aOR [95% CI 1.06-1.80], p = 0.02). Young and advanced maternal age, primiparity, obesity, smoking, and history of high blood pressure or diabetes were also associated with high global risk.

conclusionsThis prospective epidemiological study showed that the risk of clinically diagnosed imprinting-related diseases is increased in children conceived after fresh embryo transfers or from mothers with endometriosis. The increased perturbations in genomic imprinting could be caused by controlled ovarian hyperstimulation and potentially endometriosis through the impairment of endometrial receptivity and placentation, leading to epigenetic feto-placental changes. Further studies are now needed to improve understanding of the underlying molecular mechanisms (i.e. genetic or epigenetic causes).

Indexed as

AdultCase-Control StudiesChildCohort StudiesDNA MethylationEmbryo TransferEndometriosisEpigenomicsFemaleFertilization in VitroFranceGenomic ImprintingHumansInfant, NewbornInfant, Newborn, DiseasesInfertility, FemaleAssisted reproductive technologiesChildrenEpigenetic diseasesFemale infertilitySingletons

Identifiers

PMID33308308
PMCPMC7731556
OpenAlexW3112088655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.